Search for: "v. Teva Pharmaceuticals USA, Inc."
Results 81 - 100
of 440
Sort by Relevance
|
Sort by Date
22 Jan 2019, 6:17 am
Teva Pharmaceuticals USA Inc. [read post]
13 Dec 2018, 11:16 am
Teva Pharmaceuticals USA Inc., which asks: “Whether, under the Leahy-Smith America Invents Act, an inventor’s sale of an invention to a third party that is obligated to keep the invention confidential qualifies as prior art for purposes of determining the patentability of the invention. [read post]
7 Dec 2018, 11:32 am
Teva Pharmaceuticals USA Inc. [read post]
7 Dec 2018, 10:38 am
Teva Pharmaceuticals USA, Inc., et al, No. 2:17-cv-00412, 2nd am. complaint (E.D. [read post]
4 Dec 2018, 2:51 pm
Teva Pharmaceuticals USA, Inc., No. 17-1229. [read post]
4 Dec 2018, 1:21 pm
Teva Pharmaceuticals USA Inc. [read post]
4 Dec 2018, 11:16 am
Teva Pharmaceuticals USA Inc. is also available. [read post]
2 Dec 2018, 9:00 am
Teva Pharmaceuticals USA Inc. [read post]
27 Nov 2018, 9:30 am
Teva Pharmaceuticals USA Inc. presents the next one of those cases. [read post]
23 Nov 2018, 8:03 pm
Teva Pharmaceuticals USA Inc. case beginning at 4:00 pm (Eastern) on December 4, 2018 at the American University Washington College of Law in Washington, DC. [read post]
17 Oct 2018, 7:49 pm
The Federal Circuit found the district court committed no error in construing claim terms as non-limiting for nonobviousness purposes or in invalidating as obvious all asserted claims of the Copaxone patents, including a 40-milligram dosage three times per week (Teva Pharmaceuticals USA, Inc. v. [read post]
15 Oct 2018, 7:05 am
This week the Court released the calendar for arguments at the end of November and into December these cases are: Apple, Inc. v. [read post]
12 Oct 2018, 1:24 pm
Delaware of invalidity of claims:Plaintiffs-Appellants Teva Pharmaceuticals USA,Inc., Teva Pharmaceutical Industries, Ltd., Teva Neuroscience,Inc., and Yeda Research and Development Co. [read post]
24 Sep 2018, 1:08 pm
New Prime Inc. v. [read post]
10 Sep 2018, 10:17 am
Roxane was that Acorda lost:Roxane Laboratories, Inc.; Mylan Pharmaceuticals,Inc.; and Teva Pharmaceuticals USA, Inc., have submittedAbbreviated New Drug Applications seeking FDAapproval to market generic versions of Ampyra. [read post]
26 Aug 2018, 4:35 am
Teva Pharmaceuticals USA Inc., on appeal from the Federal Circuit. [read post]
26 Aug 2018, 4:35 am
Teva Pharmaceuticals USA Inc., on appeal from the Federal Circuit. [read post]
8 Aug 2018, 1:51 pm
In Wu v. [read post]
23 Jul 2018, 2:38 pm
Mylan Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., AKORN, Inc. [read post]
23 Jul 2018, 12:05 pm
Teva Pharmaceuticals USA, Inc., et al., No. 17-1229. [read post]
